The Atlantic convened experts for a discussion of the rare disease patient experience and why it is so unique. We probed these themes through conversations seeking to explore how genomics and other cutting-edge clinical innovations may transform the future of health care.
- Tuesday, February 14
- 6:30 a.m.WelcomeJocelyn Miller, AtlanticLIVE
Tolga Tanguler, President of North America, Pfizer Rare Disease
- 6:40 a.m.Looking for a Cure: The Rare Disease Patient Experience and Lysosomal Storage DiseaseCara O’Neill, Co-founder and Vice President, Cure Sanfilippo Foundation
Elsa Shapiro, Professor of Pediatrics and Neurology, Division of Pediatric Behavioral Neuroscience, University of Minnesota
With Steve Clemons, Washington Editor at Large,The Atlantic
- 7:05 a.m.When There's No Diagnosis: One Rare Disease Researcher's Hunt for AnswersHudson Freeze, Director of the Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute
Diana Papworth, Mother of Children with CDG
Shaun Papworth, CDG Patient
With Steve Clemons, The Atlantic
- 7:30 a.m.ClosingJocelyn Miller, AtlanticLIVE
Children and Cancer:
An Atlantic Forum
The Atlantic will break down the latest in immunotherapy and how it is being used to help young patients survive and thrive. And moving beyond anecdotal evidence, we'll examine how can big data can be used to track how pediatric cancers impact aspects of health for survivors down the road.